These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 7159638

  • 1. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K, Sato M, Kashihara K, Otsuki S.
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [Abstract] [Full Text] [Related]

  • 2. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K, Sato M, Otsuki S.
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [Abstract] [Full Text] [Related]

  • 3. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

  • 4. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 5. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE.
    J Neurosci Res; 1984 Dec; 12(4):571-81. PubMed ID: 6512888
    [Abstract] [Full Text] [Related]

  • 6. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG.
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [Abstract] [Full Text] [Related]

  • 7. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP, Wooten GF.
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [Abstract] [Full Text] [Related]

  • 8. Antagonism by supidimide of haloperidol-induced augmentation of [3H]-spiperone binding in rat striatum.
    Hennies HH, Hess V, Flohé L.
    Arzneimittelforschung; 1984 Apr; 34(11):1481-4. PubMed ID: 6543122
    [Abstract] [Full Text] [Related]

  • 9. [Effect of in vitro serotonin on dopaminergic binding sites in rat striatal membranes].
    Oelssner W, Raubach KH, Oelssner W.
    Biomed Biochim Acta; 1983 Apr; 42(7-8):931-6. PubMed ID: 6651809
    [Abstract] [Full Text] [Related]

  • 10. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK, Scott CE, Vazquez DM, Bhatnagar RK.
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [Abstract] [Full Text] [Related]

  • 11. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR, Molinoff PB.
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [Abstract] [Full Text] [Related]

  • 12. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA.
    Brain Res; 1983 May 09; 267(1):179-82. PubMed ID: 6860944
    [Abstract] [Full Text] [Related]

  • 13. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S, Robson PA.
    Neuropharmacology; 1981 Dec 09; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract] [Full Text] [Related]

  • 14. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
    Panagopoulos NT, Matsokis NA, Valcana T.
    J Neurosci Res; 1993 Aug 01; 35(5):499-506. PubMed ID: 8377223
    [Abstract] [Full Text] [Related]

  • 15. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
    Thal LJ, Horowitz SG, Dvorkin B, Makman MH.
    Brain Res; 1980 Jun 16; 192(1):185-94. PubMed ID: 7378779
    [Abstract] [Full Text] [Related]

  • 16. Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat.
    Agnati LF, Benfenati F, Battistini N, Cavicchioli L, Fuxe K, Toffano G.
    Acta Physiol Scand; 1983 Feb 16; 117(2):311-4. PubMed ID: 6869038
    [No Abstract] [Full Text] [Related]

  • 17. Effect of pyridoxine deficiency in young rats on high-affinity serotonin and dopamine receptors.
    Paulose CS, Dakshinamurti K.
    J Neurosci Res; 1985 Feb 16; 14(2):263-70. PubMed ID: 4046074
    [Abstract] [Full Text] [Related]

  • 18. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B, Gorissen H, Laduron PM.
    Mol Pharmacol; 1982 Sep 16; 22(2):243-9. PubMed ID: 7144728
    [Abstract] [Full Text] [Related]

  • 19. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
    Fuxe K, Agnati LF, Benfenati F, Celani M, Zini I, Zoli M, Mutt V.
    J Neural Transm Suppl; 1983 Sep 16; 18():165-79. PubMed ID: 6192208
    [Abstract] [Full Text] [Related]

  • 20. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ, Seeman P.
    Proc Natl Acad Sci U S A; 1981 Apr 16; 78(4):2620-4. PubMed ID: 6941314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.